Kim and colleagues were the first to demonstrate that overexpression of another dominant-negative STAT3, which inhibits phosphorylation of STAT3 at Tyr705, resulted in radiosensitization of human MDA-MB-231 breast cancer cells [56]. The gene discussed is STAT3; the disease is breast carcinoma.